Amira Khater/LinkedIn
Feb 23, 2026, 15:16
Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
Amira Khater, Clinical Pharmacy Specialist at Sentara Healthcare, shared on LinkedIn:
“The AHA and ACC just released their first-ever joint guideline on acute pulmonary embolism, bringing clearer structure to how we diagnose and manage PE.
A few key updates that stood out to me:
- A new A–E classification system to better define PE severity and guide treatment
- DOACs remain first-line for most patients needing anticoagulation
- Advanced therapies like thrombolysis are reserved for higher-risk patients with clinical deterioration
- Greater emphasis on risk stratification and follow-up care
This is an important step toward more consistent, risk-based care—and highlights the ongoing role of the multidisciplinary team in improving outcomes for patients with PE.”
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy